Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Tazemetostat

EU orphan designation number: EU/3/18/2005   
Active ingredient: Tazemetostat
Indication: Treatment of follicular lymphoma
Sponsor: IQVIA RDS Ireland Limited
Estuary House, East Point Business Park, Fairview, Dublin 3, DO3 Y6A2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2018 Orphan designation EMA/OD/222/17 (2018)1893 of 21/03/2018
2/05/2018 Change of name and/or address of sponsor